Skip to main content
. 2021 Jan 7;27(2):214–218. doi: 10.5152/dir.2021.19545

Table 2.

Morphological and molecular data of the analyzed samples

NSCLC
Appearance Solid/nonsolid 145/47

T stage T1a (n=5), T1b (n=47), T1c (n=56), T2a (n=31), T2b (n=23), T3 (n=22), T4 (n=8)

Histology Adenocarcinoma, 160/192
Poorly differentiated carcinoma, 5/192
Squamous carcinomas, 27/192

PD-L1 expression Adequate immunostainings, 180/192
TPS <1% in 64%,
>1% and <50% in 12%
>50% in 24%

PD-L1, programmed death–ligand 1; TPS, tumor proportion score.